Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Seattle Genetics, Inc.
60.8% sales growth and 23.4% return on equity
Seattle Genetics, Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally.
Seattle Genetics, Inc. sales growth this year is expected to be 134.9% and a negative 16.8% for next year.
Year-on-year quarterly revenue growth grew by 397.9%, now sitting on 1.86B for the twelve trailing months.
Seattle Genetics, Inc.'s sales growth for the next quarter is 60.8%. The company's growth estimates for the present quarter and the next is 478.6% and 72.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.4%.
Seattle Genetics, Inc.'s Stock Top and Bottom Yearly Value
Seattle Genetics, Inc.'s stock is valued at $179.23 at 11:57 EST, way under its 52-week high of $213.94 and way higher than its 52-week low of $90.57.
Seattle Genetics, Inc.'s Moving Average
Seattle Genetics, Inc.'s value is under its 50-day moving average of $179.74 and above its 200-day moving average of $171.22.
2. Goldman Sachs Group, Inc.
12.5% sales growth and 7.31% return on equity
The Goldman Sachs Group, Inc. operates as an investment banking, securities, and investment management company worldwide.
Goldman Sachs Group, Inc. sales growth this year is anticipated to be 14.8% and a negative 9.5% for next year.
Year-on-year quarterly revenue growth grew by 30.8%, now sitting on 39.63B for the twelve trailing months.
Goldman Sachs Group, Inc.'s sales growth for the next quarter is 12.5%. The company's growth estimates for the current quarter and the next is 28.6% and 97.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.31%.
Goldman Sachs Group, Inc.'s Stock Top and Bottom Yearly Value
Goldman Sachs Group, Inc.'s stock is valued at $244.40 at 11:57 EST, under its 52-week high of $250.46 and way above its 52-week low of $130.85.
Goldman Sachs Group, Inc.'s Moving Average
Goldman Sachs Group, Inc.'s worth is way higher than its 50-day moving average of $217.32 and way above its 200-day moving average of $207.43.
3. MorphoSys AG
176.1% sales growth and 12.31% return on equity
MorphoSys AG, together with its subsidiaries, develops and commercializes antibodies and peptides for therapeutic applications in the United States.
MorphoSys AG sales growth this year is expected to be 361.2% and a negative 31.1% for next year.
Year-on-year quarterly revenue growth grew by 76.4%, now sitting on N/A for the twelve trailing months.
MorphoSys AG's sales growth for the next quarter is 176.1%. The company's growth estimates for the current quarter and the next is a negative 0% and 61.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.31%.
MorphoSys AG's Stock Top and Bottom Yearly Value
MorphoSys AG's stock is valued at $27.43 at 11:57 EST, way below its 52-week high of $37.96 and way higher than its 52-week low of $18.21.
MorphoSys AG's Moving Average
MorphoSys AG's value is above its 50-day moving average of $26.60 and way below its 200-day moving average of $30.49.
4. Lakeland Industries, Inc.
18.9% sales growth and 21.74% return on equity
Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide.
Lakeland Industries, Inc. sales growth this year is expected to be 37.7% and a negative 11.8% for next year.
Year-on-year quarterly revenue growth grew by 27.5%, now sitting on 136.26M for the twelve trailing months.
Lakeland Industries, Inc.'s sales growth is a negative 0% for the ongoing quarter and 18.9% for the next. The company's growth estimates for the ongoing quarter and the next is 278.6% and 193.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.74%.
Lakeland Industries, Inc.'s Stock Top and Bottom Yearly Value
Lakeland Industries, Inc.'s stock is valued at $20.40 at 11:57 EST, way under its 52-week high of $28.00 and way above its 52-week low of $9.97.
Lakeland Industries, Inc.'s Moving Average
Lakeland Industries, Inc.'s worth is under its 50-day moving average of $21.67 and under its 200-day moving average of $21.05.
Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge: Late-August 2026 Funding Wave Spans Fintech, Enterprise Agents, and Robotics
A dense cluster of funding rounds landing on 2026-08-28 — from identity/fraud fintech player Socure ($156M plus its acquisition of Fravity) to enterprise AI agent startups (Instinct, Generalist AI, Owner), model infrastructure (Stability AI, Emerald AI), and autonomous logistics/aerospace (Gatik, Regent Craft) — signals investors are rotating aggressively into AI-native companies with demonstrable ROI, especially in financial risk/compliance and back-office automation. Parallel signals (Multiverse Computing's compression benchmarks cutting inference cost/latency, and Arkestro/CloneOps.ai publishing hard savings and labor-displacement figures) suggest the funding is chasing efficiency and measurable economic impact rather than pure model scale.
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
